当前位置: 首页 > 期刊 > 《中华现代内科学杂志》 > 2006年第1期
编号:10859259
左卡尼汀联合促红细胞生成素治疗肾性贫血
http://www.100md.com 《中华现代内科学杂志》 2006年第1期
贫血,,贫血;左卡尼汀;促红细胞生成素;血液透析,1资料与方法,2结果,3讨论,【参考文献】
     【摘要】 目的 观察左卡尼汀联合促红细胞生成素对维持性血液透析患者贫血治疗的效果。方法 将60例维持性血液透析患者随机分成两组。治疗组于每次血透后静脉推注左卡尼汀(雷卡)1.0g,每周2次。疗程共3个月。而对照组不用。两组同时于血液透析后皮下注射促红细胞生成素每周100~150u/kg。结果 治疗组Hb、Hct水平显著高于对照组(P<0.05)。结论 左卡尼汀(雷卡)能显著提高促红细胞生成素对血液透析患者贫血的疗效,可减少促红细胞生成素的用量。

    【关键词】 贫血;左卡尼汀;促红细胞生成素;血液透析

    Observation on the effect of renal anemia treated with L-carnitine and rhEPO

    LIU Chun,ZHOU Ze-mei,YU Wei,et al.

    The Department of Nephrology,The Third People’s Hospital of Chongqing,Chongqing 430014,China

    【Abstract】 Objective To observe the offect of renal anemia treated with L-carnitine and rhEPO.Methods 60 patients were divided into two groups randomly. Inject L-carnitine to the patients after hemodialysis tneatment group in the course of treatment in three monthes.Patients of comparison do not inget L-carnitine.Patients in two groups inget rhEPO after hemodialysis. The dose 100~150u/kg every week.Results The level of Hb and Hct of theatment group is higher than the other group.(P<0.005).Conclusion L-carnitine can improve the treatment effect to kidney anemia. Also decreace the dose of rhEPO. ......

您现在查看是摘要页,全文长 6262 字符